Genetic Study in Patients With Stage II or Stage III Colon Cancer

CompletedOBSERVATIONAL
Enrollment

598

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Colorectal Cancer
Interventions
GENETIC

DNA stability analysis

GENETIC

gene mapping

Trial Locations (59)

55805

St. Mary's/Duluth Clinic Health System, Duluth

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T1J 1W5

Lethbridge Cancer Clinic, Lethbridge

V9S 2B7

Nanaimo Cancer Clinic, Nanaimo

V3V 1Z2

British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey

V5Z 3J5

Prostate Centre at Vancouver General Hospital, Vancouver

V5Z 4E6

British Columbia Cancer Agency, Vancouver

V6Z 1Y6

St. Paul's Hospital - Vancouver, Vancouver

V8V 3N1

G. Steinhoff Clinical Research, Victoria

E1C 6ZB

Moncton Hospital, Moncton

E1C 8X3

Doctor Leon Richard Oncology Centre, Moncton

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Newfoundland Cancer Treatment and Research Foundation, St. John's

B3H 1V7

Nova Scotia Cancer Centre, Halifax

B1P 1P3

Cape Breton Cancer Centre, Sydney

L4M 6M2

Royal Victoria Hospital, Barrie, Barrie

L6W 2Z8

William Osler Health Centre, Brampton

P3E 5J1

Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury

L8N 1T8

Hamilton and District Urology Association, Hamilton

N6A 4G5

London Health Sciences Centre, London

L3P 7T3

Markham Stouffville Hospital, Markham

L5B 1B8

Trillium Health Centre, Mississauga

L5M 2N1

Credit Valley Hospital, Mississauga

L3Y 2P9

York County Hospital, Newmarket

M2K 1E1

North York General Hospital, Ontario, North York

L6H 3PI

Male Health Centre/CMX Research Inc., Oakville

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

K9H 7B6

Peterborough Oncology Clinic, Peterborough

M1P 2V5

Scarborough Hospital - General Site, Scarborough Village

L2R 5K3

Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines

P7A 7T1

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay

M4C 3E7

Toronto East General Hospital, Toronto

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital - Toronto, Toronto

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M5S 1B6

Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto

M6R 1B5

Saint Joseph's Health Centre - Toronto, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

C1A 8T5

Queen Elizabeth Hospital, PEI, Charlottetown

J1H 5N4

CHUS-Hopital Fleurimont, Fleurimont

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

J6E 6J2

Centre Hospitalier Regional de Lanaudiere, Joliette

(P.Q.) H2X 3J4

Centre Hospitalier de l'Universite de Montreal, Montreal

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H2W 1S6

McGill University, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

H4J 1C5

Hopital Du Sacre-Coeur de Montreal, Montreal

H9R 4S3

Kells Medical Research Group Inc., Pointe-Claire

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Québec

G1S 4L8

Hopital du Saint-Sacrament, Quebec, Québec

G5L 5T1

Centre Hospitalier Regional de Rimouski, Rimouski

G1V 4G5

L'Hopital Laval, Ste-Foy

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

V7L 2P9

Lions Gate Hospital, North Vancouver

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NCIC Clinical Trials Group

NETWORK

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003833 - Genetic Study in Patients With Stage II or Stage III Colon Cancer | Biotech Hunter | Biotech Hunter